© 2022 BioMarin. All rights reserved.
| Recent Price | $79.72 |
|---|---|
| 52 Week High | $94.20 |
| 52 Week Low | $71.59 |
| Average Volume (30 days) | 1.19M |
| Beta | 0.41 |
| Market Cap | $14.75B |
|---|---|
| Shares Outstanding | 185.00M |
| Float | 184.17M |
| Yield % | -- |
|---|---|
| Annual Dividend | -- |
| Payout Ratio | -285.7% |
| Quick Ratio (MRQ) | 3.0 |
|---|---|
| Current Ratio (MRQ) | 4.9 |
| LT Debt/Capital (MRQ) | 20% |
| Total Debt/Equity (MRQ) | 25% |
| Price/Earnings (TTM) | 442.90 |
|---|---|
| Price/Sales (TTM) | 7.85 |
| Price/Book (MRQ) | 3.36 |
| Price/Cash Flow (TTM) | 101.60 |
| Earnings (TTM) | $0.18 |
|---|---|
| Sales (TTM) | $10.16 |
| Book Value (MRQ) | $23.74 |
| Cash Flow (TTM) | $0.78 |
| Cash (MRQ) | $5.74 |
| Return on Equity (TTM) | 1.0% |
|---|---|
| Return on Assets (TTM) | 0.7% |
| Return on Investment (TTM) | 0.8% |
| Gross Margin (TTM) | 75.1% |
|---|---|
| EBIT Margin (TTM) | 2.7% |
| Profit Margin (TTM) | 2.3% |